04:06 PM EDT, 04/03/2024 (MT Newswires) -- Nassim Usman, Director, on April 01, 2024, sold 20,000 shares in Gyre Therapeutics ( GYRE ) for $323,000. Following the Form 4 filing with the SEC, Usman has control over a total of 2,276 shares of the company, with 1,636 shares held directly and 640 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1124105/000114036124017566/xslF345X03/form4.xml